Clinical Trial

Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions

Recruiting
View on ClinicalTrials.gov →
Summary
This clinical trial studies how well an optical imaging scan called quantitative oblique back-illumination microscopy (qOBM) helps in diagnosing skin cancer in patients with skin lesions. qOBM is a non-invasive procedure that uses red light for illumination, and may work better than no imaging procedures in aiding doctors in diagnosing skin lesions.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-10-01.
Status change: Not Yet Recruiting → Recruiting 2025-12-11
Trial Details
NCT Number NCT07213154
Lead Sponsor Emory University
Collaborators: National Cancer Institute (NCI)
Conditions Malignant Skin Neoplasm, Skin Disorder, Skin Neoplasm
Enrollment 10 participants
Start Date 2025-10-15
Primary Completion 2026-09-17 (estimated)
Study Completion 2027-09-17 (estimated)
Updated on ClinicalTrials.gov 2025-12-16